OVERVIEW OF RECENT SYSTEMATIC LITERATURE REVIEWS ON GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR WEIGHT LOSS IN ADULTS WITH OBESITY

被引：0
|
作者：
Smoyer, K. E. [1 ]
Moubarak, L. [2 ]
Singh, S. [2 ]
Kandola, S. [2 ]
机构：
[1] Envis Pharma Grp, Philadelphia, PA USA
[2] Envis Pharma Grp, London, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO4
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [41] Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
    Kang, Yu Mi
    Jung, Chang Hee
    ENDOCRINOLOGY AND METABOLISM, 2016, 31 (02) : 258 - 274
  • [42] Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity
    Burcelin, R.
    Gourdy, P.
    OBESITY REVIEWS, 2017, 18 (01) : 86 - 98
  • [43] The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
    Fang, Haowen
    Niu, Bing
    Chen, Qin
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (20) : 2921 - 2943
  • [44] Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists
    Vaduganathan, Muthiah
    Patel, Ravi B.
    Singh, Avinainder
    McCarthy, Cian P.
    Qamar, Arman
    Januzzi, James L., Jr.
    Scirica, Benjamin M.
    Butler, Javed
    Cannon, Christopher P.
    Bhatt, Deepak L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (12) : 1596 - 1598
  • [45] Glucagon-like peptide-1 receptor agonists and kidney outcomes
    MacIsaac, Richard J.
    Trevella, Philippa
    Ekinci, Elif I.
    JOURNAL OF DIABETES, 2024, 16 (10)
  • [46] Quantitative Comparison of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Adults: A Systematic Review and Model-Based Meta-Analysis
    Zhang, Shaolong
    Yu, Boran
    Xu, Jiamin
    Jin, Siyao
    Li, Yanming
    Bing, Hao
    Li, Jueyu
    Ma, Xiangyu
    Zhang, Xianhua
    Zhao, Libo
    DIABETES TECHNOLOGY & THERAPEUTICS, 2025,
  • [47] Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes: A Systematic Review of Randomized Controlled Trials
    Moiz, Areesha
    Filion, Kristian B.
    Toutounchi, Helia
    Tsoukas, Michael A.
    Yu, Oriana H. Y.
    Peters, Tricia M.
    Eisenberg, Mark J.
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (02)
  • [48] Role of lifestyle and glucagon-like peptide-1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases
    Giannakogeorgou, Anna
    Roden, Michael
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 : S52 - S75
  • [49] Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado
    Distefano, Michael J.
    Dardouri, Mouna
    Moore, Gina D.
    Saseen, Joseph J.
    Nair, Kavita V.
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2025, 18 (01)
  • [50] The effect of glucagon-like Peptide-1 receptor agonists on measures of suicidality: A systematic review
    Valentino, Kyle
    Teopiz, Kayla M.
    Cheung, William
    Wong, Sabrina
    Le, Gia Han
    Rosenblat, Joshua D.
    Mansur, Rodrigo B.
    Mcintyre, Roger S.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2025, 183 : 112 - 126
12345